About Sibylla Biotech
Sibylla Biotech is a company based in Trento (Italy) founded in 2017 by Lidia Pieri.. Sibylla Biotech has raised $25.19 million across 2 funding rounds from investors including V-Bio Ventures, Seroba Lifesciences and 3B Future Health Fund. Sibylla Biotech offers products and services including PPI-FIT Platform and Oneiros AI Platform. Sibylla Biotech operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
- Headquarter Trento, Italy
- Founders Lidia Pieri
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sibylla Biotech S.P.A.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25.19 M (USD)
in 2 rounds
-
Latest Funding Round
$22.55 M (USD), Series A
Oct 04, 2022
-
Investors
V-Bio Ventures
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sibylla Biotech
Sibylla Biotech offers a comprehensive portfolio of products and services, including PPI-FIT Platform and Oneiros AI Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-based tool for targeting protein folding in therapeutic development.
System for simulating protein folding to support drug discovery efforts.
Funding Insights of Sibylla Biotech
Sibylla Biotech has successfully raised a total of $25.19M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $22.55 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $22.5M
-
First Round
First Round
(15 Oct 2019)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series A - Sibylla Biotech | Valuation | V-Bio Ventures | |
| Oct, 2019 | Amount | Seed - Sibylla Biotech | Valuation | Vertis SGR |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sibylla Biotech
Sibylla Biotech has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include V-Bio Ventures, Seroba Lifesciences and 3B Future Health Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
V-Bio Ventures is engaged in life science venture capital investment.
|
Founded Year | Domain | Location | |
|
Early-stage healthcare investments are made by 3B Future Health Fund.
|
Founded Year | Domain | Location | |
|
Claris Ventures is engaged in early-stage biotech venture investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sibylla Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sibylla Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sibylla Biotech Comparisons
Competitors of Sibylla Biotech
Sibylla Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An agentic AI platform is developed for biomedical research insights.
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| domain | founded_year | HQ Location |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| domain | founded_year | HQ Location |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| domain | founded_year | HQ Location |
AI platform used for extracting antibody data from scientific papers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Sibylla Biotech
When was Sibylla Biotech founded?
Sibylla Biotech was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Where is Sibylla Biotech located?
Sibylla Biotech is headquartered in Trento, Italy. It is registered at Trento, Trentino-alto Adige, Italy.
Who is the current CEO of Sibylla Biotech?
Lidia Pieri is the current CEO of Sibylla Biotech. They have also founded this company.
Is Sibylla Biotech a funded company?
Sibylla Biotech is a funded company, having raised a total of $25.19M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.65M, raised on Oct 15, 2019.
What does Sibylla Biotech do?
Sibylla Biotech was founded in 2017 in Trento, Italy, within the biotechnology sector. An AI-driven platform is employed for drug discovery, utilizing the Pharmacological Protein Inactivation by Folding Intermediates Targeting (PPI-FIT) approach. Small molecules are identified and developed to act on targets such as Cyclin D1 and KRAS, addressing oncology and inflammatory diseases through its pipeline.
Who are the top competitors of Sibylla Biotech?
Sibylla Biotech's top competitors include Owkin, Formation Bio and XtalPi.
What products or services does Sibylla Biotech offer?
Sibylla Biotech offers PPI-FIT Platform and Oneiros AI Platform.
Who are Sibylla Biotech's investors?
Sibylla Biotech has 9 investors. Key investors include V-Bio Ventures, Seroba Lifesciences, 3B Future Health Fund, Claris Ventures, and CDP Venture Capital.